Publications

• Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies.

  (Gibbs P, Heinemann V, Sharma NK, Taieb J, Ricke J, Peeters M, Findlay M, Robinson B, Jackson C, Strickland A, Gebski V, Van Buskirk M, Zhao H, van Hazel G, SIRFLOX and FOXFIRE Global Trial Investigators.) Clin Colorectal Cancer. 2018 12;17(4):e617-e629.

• A Multi-institutional Comparison of Adrenal Venous Sampling in Patients with Primary Aldosteronism: Caution Advised if Successful Bilateral Adrenal Vein Sampling is Not Achieved.

  (Wang TS, Kline G, Yen TW, Yin Z, Liu Y, Rilling W, So B, Findling JW, Evans DB, Pasieka JL.) World J Surg. 2018 02;42(2):466-472.

• Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.

  (Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, Magnuson E, Razavi MK, Comerota AJ, Gornik HL, Murphy TP, Lewis L, Duncan JR, Nieters P, Derfler MC, Filion M, Gu CS, Kee S, Schneider J, Saad N, Blinder M, Moll S, Sacks D, Lin J, Rundback J, Garcia M, Razdan R, VanderWoude E, Marques V, Kearon C, ATTRACT Trial Investigators.) N Engl J Med. 2017 12 07;377(23):2240-2252.

• Multicenter Trial of the VenaTech Convertible Vena Cava Filter.

  (Hohenwalter EJ, Stone JR, O'Moore PV, Smith SJ, Selby JB, Lewandowski RJ, Samuels S, Kiproff PM, Trost DW, Madoff DC, Handel J, Gandras EJ, Vlahos A, Rilling WS.) J Vasc Interv Radiol. 2017 Oct;28(10):1353-1362.

• First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.

  (Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J, Peeters M, Findlay M, Weaver A, Mills J, Wilson C, Adams R, Francis A, Moschandreas J, Virdee PS, Dutton P, Love S, Gebski V, Gray A, FOXFIRE trial investigators, SIRFLOX trial investigators, FOXFIRE-Global trial investigators, van Hazel G, Sharma RA.) Lancet Oncol. 2017 09;18(9):1159-1171.

• Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis.

  (Silva JP, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, White S, Rilling W, Gamblin TC.) HPB (Oxford). 2017 08;19(8):659-666.

• Geniculate Artery Embolization for Management of Recurrent Hemarthrosis: A Single-Center Experience.

  (Ogilvie ME, Tutton SM, Neilson JC, Rilling WS, Hohenwalter EJ.) J Vasc Interv Radiol. 2016 Jul;27(7):1097-9.

• Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data.

  (Lencioni R, de Baere T, Soulen MC, Rilling WS, Geschwind JF.) Hepatology. 2016 07;64(1):106-16.

• 90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study.

  (Hickey R, Lewandowski RJ, Prudhomme T, Ehrenwald E, Baigorri B, Critchfield J, Kallini J, Gabr A, Gorodetski B, Geschwind JF, Abbott A, Shridhar R, White SB, Rilling WS, Boyer B, Kauffman S, Kwan S, Padia SA, Gates VL, Mulcahy M, Kircher S, Nimeiri H, Benson AB, Salem R.) J Nucl Med. 2016 May;57(5):665-71.

• Evaluation of catheter infection rates in converted dialysis catheters versus de novo placement in the setting of chlorhexidine use.

  (Criddle JM, Hieb RA, White SB, Patel PJ, Hohenwalter EJ, Tutton SM, Rilling WS.) J Vasc Access. 2016 Mar-Apr;17(2):162-6.

• Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-Analysis.

  (Zacharias AJ, Jayakrishnan TT, Rajeev R, Rilling WS, Thomas JP, George B, Johnston FM, Gamblin TC, Turaga KK.) PLoS One. 2015;10(10):e0139940.

• Palliative Interventional Oncology.

  (Fairchild AH, Rilling WS.) Cancer J. 2016 Nov/Dec;22(6):411-417.